Clinical Trials List
2020-06-01 - 2029-05-31
Phase III
Recruiting7
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ching-Shan Luo Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- Kuang-Tai Kuo Division of Thoracic Surgery
- JING-QUAN ZHENG Division of Thoracic Medicine
- Tzu-Tao Chen Division of Thoracic Medicine
- Shiou-Fu Lin Division of Others -
- YEN-HAN TSENG Division of Thoracic Medicine
- YUN-KAI YEH Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yuh-Min Chen Division of Thoracic Medicine
- Han-Shui Hsu Division of Thoracic Surgery
- Chia-I Shen Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Yung-Hung Luo Division of Hematology & Oncology
- Hsu-ching Huang Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- Yi-Chen Yeh Division of General Surgery
- Chao-Hua Chiu Division of Thoracic Medicine
- Heng-Sheng Chao 未分科
- YEN-HAN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文聰 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chong-Jen Yu Division of Thoracic Medicine
- 許嘉林 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Hsao-Hsun Hsu Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- SHUENN-WEN KUO Division of Hematology & Oncology
- YEN-TING LIN Division of Cardiovascular Diseases
- 廖唯昱 Division of Hematology & Oncology
- 吳尚俊 Division of Thoracic Medicine
- 廖斌志 Division of Hematology & Oncology
- Mong-Wei Lin Division of Thoracic Surgery
- 陳冠宇 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- JIN-SHING CHEN Division of Hematology & Oncology
- 陳克誠 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Pai-Chien Chou Division of Thoracic Medicine
- Chi-Long Chen Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
- 鍾政錦 Division of Thoracic Medicine
- Chun-Liang Chou Division of Thoracic Medicine
- Yu-Chung Wu Division of Thoracic Surgery
- Chao-Hua Chiu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 陳鴻仁 Division of Thoracic Medicine
- Wen-Chien Cheng Division of Thoracic Medicine
- Chih-Yen Tu Division of Thoracic Medicine
- Yu-Sen Lin Division of Thoracic Surgery
- Yu-Chao Lin Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
351 participants
